Drug related to resveratrol showing promise in extending lifespan of the obese
The human race has been on a quest for the fountain of youth for as long as it has been able to reflect on its own mortality. Researchers from many fields continue to pursue the holy grail of longevity, including geneticists, biochemists and nanotechnologists. Now researchers who have synthesized a compound originally discovered in red wine say they are on to something.
The drug, SRT-1720, appears to substantially extend the average life span of mice, even ones which are obese. In fact, it seems to protect obese mice by reducing the amount of fat in the liver and increasing sensitivity to insulin, despite the mice love handles. These and other positive health effects enable the obese mice to live 44 percent longer, on average, than obese mice that did not receive the drug, according to a team of researchers led by Rafael de Cabo, a gerontologist at the National Institute on Aging.
The findings “demonstrate for the first time the feasibility of designing novel molecules that are safe and effective in promoting longevity and preventing multiple age-related diseases in mammals,” Dr. de Cabo and colleagues write in Thursday’s issue of the new journal Scientific Reports.
The scientists stress that they are not looking for a drug which will enable us to live an over-indulgent lifestyle free of consequences, but rather, they are looking for a substance which will stave off the degenerative effects of normal aging. The idea is to come up with a compound which mimics the effects of a very low-calorie diet – which has been demonstrated to extend health and longevity significantly – without the brutal regimen of such an eating plan. Remember that in previous animal trials, obese, diabetic mice lifespans were extended 30 percent by the consumption of resveratrol – but that extension simply caught up to the normal, non-obese mice lifespan. In other words, resveratrol might curtail an early death for those who abuse their health, not give them extra or even particularly healthy, years.
“The drugs could be used as a preventative to stave off diseases, but I don’t think they will ever be an excuse to abuse your body,” said David Sinclair, a biologist at Harvard Medical School and co-chairman of the scientific advisory board of Sirtris, which developed SRT-1720.